These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1248 related articles for article (PubMed ID: 9140564)
21. [Clinical pharmacology of enalapril in hypertension with chronic renal failure]. Chaignon M; Billaud-Mesguich E; Alexandre JM; Guédon J Arch Mal Coeur Vaiss; 1986 Jun; 79(6):967-70. PubMed ID: 3026274 [TBL] [Abstract][Full Text] [Related]
22. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163 [TBL] [Abstract][Full Text] [Related]
23. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system. Schalekamp MA; Derkx FH; van den Meiracker AH J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650 [TBL] [Abstract][Full Text] [Related]
24. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674 [TBL] [Abstract][Full Text] [Related]
25. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure. Tang WH; Vagelos RH; Yee YG; Fowler MB Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323 [TBL] [Abstract][Full Text] [Related]
26. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
27. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers]. Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357 [TBL] [Abstract][Full Text] [Related]
28. The integrated concentration of plasma renin activity and aldosterone in essential hypertension. Kowarski AA; Edwin CM; Akesode AP; Piotrowski LS; Hamilton BP Johns Hopkins Med J; 1978 Feb; 142(2):35-8. PubMed ID: 625094 [TBL] [Abstract][Full Text] [Related]
29. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade. Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790 [TBL] [Abstract][Full Text] [Related]
30. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
31. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system. Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721 [TBL] [Abstract][Full Text] [Related]
32. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition. Tokita Y; Franco-Saenz R; Mulrow PJ Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072 [TBL] [Abstract][Full Text] [Related]
33. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms involved in two-kidney renal hypertension induced by constriction of one renal artery. Freeman RH; Davis JO; Watkins BE; Lohmeier TE Circ Res; 1977 May; 40(5 Suppl 1):I29-35. PubMed ID: 870229 [TBL] [Abstract][Full Text] [Related]
36. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. van den Born BJ; Koopmans RP; van Montfrans GA Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041 [TBL] [Abstract][Full Text] [Related]
37. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats]. Grima M; Anjuère J; Ingert C; Coquard C; Steger J; Barthelmebs M; Imbs JL Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker. Saleh FH; Jurjus AR J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424 [TBL] [Abstract][Full Text] [Related]
39. Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake. Olsen ME; Meydrech EF J Hypertens; 1985 Oct; 3(5):517-25. PubMed ID: 2999230 [TBL] [Abstract][Full Text] [Related]
40. Renin-angiotensin-aldosterone system in arterial hypertension. Horký K; Gregorová I Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]